If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTime Finance Regulatory News (TIME)

Share Price Information for Time Finance (TIME)

Share Price is delayed by 15 minutes
Get Live Data
50.50    2.00 (4.12%)
Bid:
50.00
Ask:
51.00
Spread: 1.00 (2.00%)
Market Cap: £46.30m
TIME Live PriceLast checked at - London Stock Exchange

Intraday Time Finance Share Chart

Loan Book Update

12 Nov 2025 07:00

RNS Number : 0472H
Time Finance PLC
12 November 2025
 

12 November 2025

Time Finance plc

("Time Finance", the "Group" or the "Company")

 

Loan Book Update

 

Lending Book hits £230m to reach an all-time high

 

Time Finance plc, the AIM listed independent specialist finance provider is pleased to provide the following update on the performance of its lending book portfolio. Increasing the Company's own-book lending forms a key pillar of the Group's three-year growth strategy which targets the gross lending portfolio reaching £300m by 31 May 2028.

 

The Company also reconfirms notice of upcoming investor events and key financial dates

 

Record Lending Book

 

As at 31 October 2025, the unaudited value of the Group's lending portfolio reached a record high of £230m. The lending portfolio, therefore, stands 6% higher than the 31 May 2025 financial year-end level of £217m, and 12% up on the 31 October 2024 equivalent of £205m.

 

Within the lending book itself, the two key strategic growth areas of Invoice Finance and the 'Hard' subset of Asset Finance, have also both achieved all-time record highs. The Invoice Finance lending book stands in excess of £75m, up over 13% from the prior year equivalent (31 October 2024: £66m). The Hard subset of the Asset division has exceeded £123m, up over 28% from the prior-year equivalent (31 October 2024: £96m). Combined, these two lending segments mean that the secured lending element within the Group's portfolio now exceeds 86%, another record high.

 

This ongoing positive lending book growth provides the Board with increased confidence that Group financial performance for FY 2025/26 will be at least in line with current market expectations.

 

Investor Presentations and Key Dates

 

As announced on 28 October 2025, and in advance of the publication of the Group's full H1 2025/26unaudited Interim Results on 27 January 2026, the Group is planning to publish an H1 Trading Update, covering the six months to 30 November 2025, on Tuesday 16 December 2025.

 

Ed Rimmer, CEO, and James Roberts, CFO, will also be presenting at two upcoming investor events on Wednesday 19 November 2025, Mello London and Yellowstone Advisory. Further information with regards the Mello event can be found here https://www.melloevents.com/mellolondon2025, while details of the Yellowstone event can be found here Join Webinars & Events | Yellowstone Advisory.

 

Ends

 

For further information, please contact:

Time Finance plc

01225 474230

Ed Rimmer (CEO) / James Roberts (CFO)

ir@timefinance.com

Cavendish (NOMAD and Broker)

0207 220 0500

Ben Jeynes / Teddy Whiley (Corporate Finance)

Michael Johnson / Matt Lewis (Sales and ECM)

Walbrook PR

0207 933 8780

Nick Rome / Joe Walker

Timefinance@walbrookpr.com

 

Subscribe to our news alert service: https://investors.timefinance.com/auth/signup

 

About Time Finance:

Time Finance's purpose is to help UK businesses thrive and survive through the provision of flexible funding facilities. It offers a multi-product range for SMEs primarily concentrating on Asset Finance and Invoice Finance. While focussed on being an 'own-book' lender, the Group does retain the ability to broke-on deals where appropriate, enabling it to optimize business levels through market and economic cycles.

 

More information is available on the Company website, www.timefinance.com, and the interactive investor hub, https://investors.timefinance.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDPKDBKCBDKKDD
Date   Source Headline
1st Oct 20217:00 amRNSVesting of Share Options
21st Sep 20217:00 amRNS2021 Final Results
7th Sep 20217:00 amRNSNotice of Final Results and Investor Presentation
16th Jun 20217:00 amRNSYear-end Trading Update
10th Jun 20217:00 amRNSPermanent CEO Appointment & Investor Presentation
4th Jun 202111:30 amRNSHolding(s) in Company
4th Jun 202111:25 amRNSHolding(s) in Company
27th May 20215:29 pmRNSEmployee Benefit Trust Share Purchase
27th May 20217:00 amRNSExercise of Options
21st May 20217:00 amRNSUnapproved Share Option Scheme – Vesting of Awards
6th May 20217:00 amRNSNew Loan Accreditation & Financial Calendar Update
22nd Apr 20217:00 amRNSCorporate Update
9th Apr 20212:58 pmRNSEmployee Benefit Trust Share Purchase
26th Mar 20217:00 amRNSDirectorate Change
3rd Mar 20217:00 amRNSFurther re Directorate Change
19th Feb 202112:04 pmRNSDirectorate Changes
3rd Feb 20217:00 amRNSTechnology Infrastructure Update
19th Jan 20217:00 amRNSInterim Results
12th Jan 20217:00 amRNSHolding in Company
12th Jan 20217:00 amRNSHolding in Company
6th Jan 20217:00 amRNSDirectorate Changes
15th Dec 20205:15 pmRNSTR-1: Holding in Company - CORRECTION
9th Dec 20207:00 amRNSHalf Year Trading Update & Investor Presentation
1st Jun 20103:19 pmRNSResult of EGM
28th May 20107:00 amRNSUpdate
6th May 20108:37 amRNSStrategic Review - update
6th May 20107:01 amRNSNotice of EGM
6th May 20107:00 amRNSAppointment of adviser
4th May 201011:22 amRNSForm 8.3 - Timestrip PLC
4th May 20107:00 amRNSForm 8 (OPD) Timestrip
19th Apr 20107:30 amRNSStrategic Review Update and Suspension
19th Apr 20107:30 amRNSSuspension - Timestrip plc
24th Mar 20109:50 amRNSRule 8.1- (Timestrip)
19th Mar 201012:47 pmRNSStrategic Review - Update
18th Mar 20107:00 amRNSStrategic Review
5th Feb 20109:04 amRNSDirectorate Change
3rd Feb 20104:29 pmRNSAIM Rule 17
1st Feb 20107:00 amRNSContract Win - Toothbrush Order
5th Nov 200912:23 pmRNSUK Packaging Awards
28th Oct 20097:00 amRNSTimestrip IV - First full adoption by NHS Trust
26th Oct 20097:00 amRNSTimestrip Medical - 1st order in North America
14th Sep 20097:01 amRNSHalf Yearly Report
14th Sep 20097:00 amRNSNHS trials and appointment of distributor
24th Jul 20092:18 pmRNSResult of AGM
6th Jul 20097:00 amRNSNew distribution agreement
1st Jul 20097:00 amRNSPreliminary findings on Timestrip IV
29th Jun 20091:26 pmRNSNotice of AGM
11th Jun 20097:00 amRNSFinal Results
8th May 20097:00 amRNSIssue of Equity
5th May 20097:00 amRNSLuton & Dunstable Hospital orders TimestripIV

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.